Update shared on06 Aug 2025
Fair value Increased 869%The significant upward revision in Vivid Seats’ fair value is primarily driven by improved revenue growth expectations and a markedly lower future P/E multiple, leading to a consensus analyst price target increase from $2.72 to $8.82.
What's in the News
- Vivid Seats approved an amendment allowing a reverse stock split of its Class A and Class B common stock, at a ratio between 1-for-5 and 1-for-30, with the specific ratio to be set by the Board.
- A 1-for-20 reverse stock split or significant stock dividend was announced.
- Vivid Seats was added to multiple major value-oriented indices, including Russell 2000 Value, Russell 2500 Value, Russell 3000 Value, Russell 3000E Value, and the Russell Small Cap Comp Value benchmarks.
Valuation Changes
Summary of Valuation Changes for Vivid Seats
- The Consensus Analyst Price Target has significantly risen from $2.72 to $8.82.
- The Consensus Revenue Growth forecasts for Vivid Seats has significantly risen from 0.4% per annum to 3.5% per annum.
- The Future P/E for Vivid Seats has significantly fallen from 51.51x to 4.66x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.